<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Neuroinflammation</journal-id>
<journal-id journal-id-type="iso-abbrev">J Neuroinflammation</journal-id>
<journal-title-group>
<journal-title>Journal of Neuroinflammation</journal-title>
</journal-title-group>
<issn pub-type="epub">1742-2094</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30180853</article-id>
<article-id pub-id-type="pmc">6122456</article-id>
<article-id pub-id-type="publisher-id">1297</article-id>
<article-id pub-id-type="doi">10.1186/s12974-018-1297-z</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Macrophage migration inhibitory factor facilitates production of CCL5 in astrocytes following rat spinal cord injury</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhou</surname>
<given-names>Yue</given-names>
</name>
<address>
<email>1026054860@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Guo</surname>
<given-names>Wei</given-names>
</name>
<address>
<email>guowcn@163.com</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhu</surname>
<given-names>Zhenjie</given-names>
</name>
<address>
<email>zhuzhenjie@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hu</surname>
<given-names>Yuming</given-names>
</name>
<address>
<email>13515215105@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yingjie</given-names>
</name>
<address>
<email>wyj2010@ntu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xuejie</given-names>
</name>
<address>
<email>ricky320@126.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Wenjuan</given-names>
</name>
<address>
<email>503737592@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Nan</given-names>
</name>
<address>
<email>dunan0713@sina.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Song</surname>
<given-names>Tiancheng</given-names>
</name>
<address>
<email>784064751@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Kaini</given-names>
</name>
<address>
<email>3158489229@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guan</surname>
<given-names>Zongyu</given-names>
</name>
<address>
<email>593601823@qq.com</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wang</surname>
<given-names>Yongjun</given-names>
</name>
<address>
<phone>0086-513-85051818</phone>
<email>wyjbs@ntu.edu.cn</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Aisong</given-names>
</name>
<address>
<phone>0086-513-85051818</phone>
<email>15851300188@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.440642.0</institution-id><institution>Department of Rehabilitation Medicine, </institution><institution>Affiliated Hospital of Nantong University, </institution></institution-wrap>Nantong, 226001 People’s Republic of China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9530 8833</institution-id><institution-id institution-id-type="GRID">grid.260483.b</institution-id><institution>Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Neuroregeneration, </institution><institution>Nantong University, </institution></institution-wrap>Nantong, 226001 People’s Republic of China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9255 8984</institution-id><institution-id institution-id-type="GRID">grid.89957.3a</institution-id><institution>School of Basic Medical Sciences, </institution><institution>Nanjing Medical University, </institution></institution-wrap>Nanjing, People’s Republic of China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9530 8833</institution-id><institution-id institution-id-type="GRID">grid.260483.b</institution-id><institution>Medical College, </institution><institution>Nantong University, </institution></institution-wrap>Nantong, 226001 People’s Republic of China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>15</volume>
<elocation-id>253</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>4</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Astrocytes act as immune effector cells with the ability to produce a wide array of chemokines and cytokines in response to various stimuli. Macrophage migration inhibitory factor (MIF) is inducibly expressed in injured spinal cord contributing to excessive inflammation that affects motor functional recovery. Unknown is whether MIF can facilitate inflammatory responses through stimulating release of chemokines from astrocytes following spinal cord injury.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">Following the establishment of the contusion spinal cord injury rat model, the correlation of chemokine (C-C motif) ligand 5 (CCL5) expression with that of MIF was assayed by Western blot, ELISA, and immunohistochemistry. Immunoprecipitation was used to detect MIF interaction with membrane CD74 receptor. Intracellular signal transduction of MIF/CD74 axis was analyzed by transcriptome sequencing of primary astrocytes and further validated by treatment of various inhibitors. The effects of CCL5 released by astrocytes on macrophage migration were performed by transwell migration assay. The post-injury locomotor functions were assessed using the Basso, Beattie, and Bresnahan (BBB) locomotor scale.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">The protein levels of chemokine CCL5/RANTES were remarkably increased in the astrocytes of rat injured spinal cord, in parallel with the expression of MIF. Treatment of MIF inhibitor 4-IPP in the lesion sites resulted in a significant decrease of CCL5 protein levels. In vitro study revealed MIF was capable of facilitating CCL5 production of astrocytes through interaction with CD74 membrane receptor, and knockdown of this receptor attenuated such effects. Production of CCL5 in astrocytes was significantly blocked by inhibitor of c-Jun N-terminal kinase, rather than by those of ERK and P38. Recombinant CCL5 protein was found to be more effective in promoting migration of M2- compared to M1-type macrophages.</p>
</sec>
<sec>
<title>Conclusion</title>
<p id="Par4">Collectively, these data reveal a novel function of MIF in regulation of CCL5 release from astrocytes, which in turn favors for recruitment of inflammatory cells to the injured site of the spinal cord, in association with activation of excessive inflammation.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12974-018-1297-z) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>MIF</kwd>
<kwd>CCL5</kwd>
<kwd>Spinal cord</kwd>
<kwd>Astrocyte</kwd>
<kwd>Inflammation</kwd>
<kwd>Chemokines</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id>
<institution>National Natural Science Foundation of China</institution>
</institution-wrap>
</funding-source>
<award-id>31871211</award-id>
<principal-award-recipient>
<name>
<surname>Wang</surname>
<given-names>Yongjun</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>NSFC</institution>
</funding-source>
<award-id>31471011; 31640042</award-id>
<principal-award-recipient>
<name>
<surname>Wang</surname>
<given-names>Yongjun</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par16">The central nervous system (CNS) can activate innate immune responses by sensing pathogens or tissue damages [<xref ref-type="bibr" rid="CR1">1</xref>]. Upon acute traumatic spinal cord injury, the resident immune and glial cells are rapidly motivated to release various cytokines and chemokines, which further induce leukocyte infiltration to the injury sites [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Astrocytes are the most abundant glial cell contributing to the functional homeostasis of the healthy CNS. They can also receive and integrate information from synapses, other glial cells, and the blood vessels and as a consequence generate complex outputs that control the neural circuitry and coordinate it with the local microcirculation [<xref ref-type="bibr" rid="CR4">4</xref>]. Astrocytes have been shown to participate in local inflammatory responses [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR8">8</xref>]. In the context of inflammatory or otherwise pathological conditions, the activated astrocytes proliferate and produce a wide variety of cytokines and chemokines, including CCL2 (monocyte chemotactic protein-1), CCL5 (RANTES), and CXCL8 (IL-8), which are associated with the recruitment of immune cells of alternative activation status [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. These recruited microglia/macrophages play either a pro-inflammatory (M1) or anti-inflammatory (M2) role as seen in a spinal cord injury model or neuroinflammatory diseases like multiple sclerosis (MS) [<xref ref-type="bibr" rid="CR10">10</xref>]. Chemokine (C-C motif) ligand 5 (CCL5) may serve to amplify inflammatory responses by facilitating the recruitment of inflammatory cells into autoimmune lesions [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. As such, astrocyte-released cytokines and chemokines which contribute to inflammatory responses will inevitably exacerbate the neuropathological changes following CNS injury.</p>
<p id="Par17">Macrophage migration inhibitory factor (MIF) is a pro-inflammatory cytokine produced by a variety of cells and tissues, including monocytes, the anterior pituitary gland, T-lymphocytes, hepatocytes, and keratinocytes [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. MIF has been found to be constitutively or inducibly expressed in astrocytes, neurons, microglia, ependymal cells, and epithelial cells of the choroid plexus in the CNS [<xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Besides its roles of inducing neuronal death and activating inflammatory episodes in microglia, MIF is capable of promoting proliferation and inflammatory cytokine production of astrocytes [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Deletion of MIF has been shown to promote functional recovery after compression-induced spinal cord injury [<xref ref-type="bibr" rid="CR17">17</xref>], suggesting that MIF plays key roles in the neuropathogenesis of injured spinal cord. Astrocytes are the main sources of chemokines involved in recruitment of inflammatory cells; whether MIF is able to induce the release of chemokines from the cells remains unclear.</p>
<p id="Par18">Astrocytes are endowed with the ability to secrete cytokines through expressing an array of receptors involved in innate immunity, such as Toll-like receptors and nucleotide-binding oligomerization domains [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Also, the cells express CD74 surface receptor which can interact with MIF to elicit inflammatory responses after spinal cord injury (SCI) [<xref ref-type="bibr" rid="CR18">18</xref>]. As MIF/CD74 axis has been found to activate intracellular MAPKs of astrocytes, an intermediate signaling essential for regulation of CCL5 and other chemokines [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>], MIF/CD74 axis is therefore postulated to mediate the production of CCL5 in astrocytes, which has been identified to promote inflammatory cell recruitment. In the present study, we analyzed the correlations between expression of MIF and CCL5 in the injured spinal cord of rat. We further investigated MIF-induced production of CCL5 in the astrocytes, as well as the underlying molecular mechanism. Our results have revealed that MIF affects pathological changes of the injured spinal cord through not only activation of astrocyte inflammatory responses, but also promoting release of chemokines.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Animals</title>
<p id="Par19">Adult male Sprague–Dawley (SD) rats, weighing 180–220 g, were provided by the Center of Experimental Animals, Nantong University. All animal care, breeding, and testing procedures were approved according to the Animal Care and Use Committee of Nantong University and the Jiangsu Province Animal Care Ethics Committee. All animals were housed in individual cages in a temperature and light/dark cycle controlled environment with free access to food and water.</p>
</sec>
<sec id="Sec4">
<title>Establishment of the contusion SCI rat model</title>
<p id="Par20">The number of animals subjected to surgical treatment was calculated by six per experimental group in triplicate. The contusion SCI rat model was prepared as the previous description [<xref ref-type="bibr" rid="CR23">23</xref>]. Briefly, rats were anesthetized with an intraperitoneal injection of 10% chloral hydrate (3 mg/kg). The fur was shaved from the surgical site and the skin was disinfected with chlorhexidine. A 15-mm midline skin incision was made to expose the vertebral column. After the spinal thoracic region was exposed by separation of the dorsal muscles to the side, the spinous processes of T8–T10 vertebrae were exposed. A laminectomy was performed at vertebral level T9, exposing the dorsal cord surface with the dura remaining intact. The exposed spinal cord segment (about 3 mm in length) received a 150-kilodyne spinal contusion injury using the IH-0400 Impactor (Precision Systems and Instrumentation) injury device. The impact rod was removed immediately, and the wound was irrigated. Muscles and incisions were sutured using silk threads. Postoperative care included butorphanol administration twice a day for a 5-day period, as well as vitamins, saline, and enrofloxacin twice a day for a 7-day period. Manual expression of the bladders was performed twice a day until animals recovered spontaneous voiding.</p>
</sec>
<sec id="Sec5">
<title>Cell culture</title>
<p id="Par21">Astrocytes were prepared from the spinal cord of newborn Sprague–Dawley rats, 1–2 days after birth, and the astrocytes were isolated and cultured according to previously described methods [<xref ref-type="bibr" rid="CR24">24</xref>]. Briefly, the cells were enzymatically dissociated using 0.25% trypsin (Gibco-BRL) for 6 min at 37 °C, and the suspension was then centrifuged at 1200 rpm for 5 min and cultured in 1:1 Dulbecco’s modified Eagle’s medium to Ham’s F-12 medium supplemented with 10% fetal bovine serum (FBS), 0.224% NaHCO<sub>3</sub>, and 1% penicillin/streptomycin in the presence of 5% CO<sub>2</sub>. A monolayer of astrocytes was obtained 12–14 days after the plating. Non-astrocytes were detached from the flasks by shaking and were removed by changing the medium. Third or fourth passage cells were rendered quiescent through incubation in the medium containing 0.5% FBS for 4 days prior to the experiments. Astrocyte phenotype was confirmed by cells exhibiting a characteristic morphology and positive staining for the astrocytic marker glial fibrillary acid protein (GFAP).</p>
</sec>
<sec id="Sec6">
<title>Western blot</title>
<p id="Par22">Protein was extracted from cells with a buffer containing 1% SDS, 100 mM Tris-HCl, 1 mM PMSF, and 0.1 mM β-mercaptoethanol, following treatment with 0.5 μg/ml rat recombinant MIF (ProSpec) for 15 min, 30 min, and 60 min, respectively. Alternatively, protein was extracted from 1-cm spinal segments of the injured site at 0 day, 1 day, 4 days, and 1 week following contusion (<italic>n</italic> = 8 in each time point). Protein concentration of each specimen was detected by the Bradford method to maintain the same loads. Protein extracts were heat-denatured at 95 °C for 5 min, electrophoretically separated on 10% SDS-PAGE, and transferred to PVDF membranes. The membranes were subjected to the reaction with a 1:1000 dilution of primary antibodies in TBS buffer at 4 °C overnight, followed by a reaction with the secondary antibody conjugated with goat anti-rabbit or goat anti-mouse HRP dilution 1:1000 (Santa Cruz) at room temperature for 2 h. After the membrane was washed, the HRP activity was detected using an ECL kit. The image was scanned with a GS800 Densitometer Scanner (Bio-Rad), and the data were analyzed using PDQuest 7.2.0 software (Bio-Rad). β-actin (1:5000) was used as an internal control. The antibodies used in Western blot are as follows: MIF (Abcam); p65NFκB (Cell Signaling Technology, CST), p-ERK1/2, and ERK1/2 (CST); and CD74 (Biorbyt) and β-actin (Proteintech).</p>
</sec>
<sec id="Sec7">
<title>ELISA</title>
<p id="Par23">Primary astrocytes were treated with 0–2.5 μg/ml rat recombinant MIF for 24 h, or tissue samples of spinal segments were prepared as mentioned (<italic>n</italic> = 6 in each time point). Cell supernatants were harvested, and cells were lysed in the buffer containing 1% SDS, 100 mM Tris-HCl, 1 mM PMSF, and 0.1 mM β-mercaptoethanol. The lysates were centrifuged at 12,000<italic>g</italic> for 15 min. Levels of CCL5 were assessed using the appropriate ELISA kits (BD Biosciences, R&amp;D Systems) according to the manufacturer’s directions. Plates were read using a 96-well plate reader (Biotek Synergy2) at a 450-nm wavelength.</p>
</sec>
<sec id="Sec8">
<title>Tissue immunohistochemistry</title>
<p id="Par24">The vertebra segments were harvested from six experimental models of each time point, post-fixed, and sectioned. Sections were allowed to incubate with monoclonal MIF antibody (1:200 dilution), rabbit anti-IBA-1 antibody (1:400 dilution, Wako), polyclonal rabbit anti-CCL5 antibody (1:200 dilution, novusbio), or monoclonal mouse anti-human GFAP antibody (1:400 dilution, Sigma) at 4 °C for 36 h. The sections were further reacted with the FITC-labeled secondary antibody goat anti-mouse IgG (1:400 dilution, Gibco) or the TRITC-labeled secondary antibody donkey anti-rabbit IgG (1:400 dilution, Gibco) at 4 °C overnight, followed by observation under a confocal laser scanning microscope (Leica, Heidelberg, Germany).</p>
</sec>
<sec id="Sec9">
<title>Immunoprecipitation</title>
<p id="Par25">The primary astrocytes were washed twice with cold phosphate-buffered saline and then extracted with lysis buffer (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM β-glycerolphosphate, 1 mM Na<sub>3</sub>VO<sub>4</sub>, 1 mM phenylmethylsulfonyl fluoride, and Roche Applied Science’s complete protease inhibitors). Whole-cell extracts were centrifuged at 14,000 rpm for 20 min to remove the debris. The proteins in the supernatant were measured using a Protein Assay Kit II (Bio-Rad). For immunoprecipitation analysis, 500 μg of total cell lysates was precleared with protein A plus G-Sepharose before incubation with specific antibodies, followed by addition of protein A plus G-Sepharose. The precipitated proteins were resolved in 2× SDS-PAGE sample buffer and separated by electrophoresis on 10–12% SDS-PAGE. After being transferred onto a polyvinylidene difluoride membrane (Millipore Corp.), they were incubated with anti-MIF or anti-CD74 antibody and further with horseradish peroxidase-conjugated secondary antibody (Santa Cruz).</p>
</sec>
<sec id="Sec10">
<title>Transwell migration assay</title>
<p id="Par26">Migration of RAW264.7 cells were measured using 6.5-mm transwell chambers with 8-μm pores (Costar, Cambridge, MA) as described previously [<xref ref-type="bibr" rid="CR25">25</xref>]. A total of 100 μl of RAW264.7 cells (2 × 10<sup>5</sup> cells/ml) was transferred into the top chamber of the transwells and allowed to migrate at 37 °C in 5% CO<sub>2</sub>. Meanwhile, 600 μl of astrocytes (1 × 10<sup>5</sup> cells/ml) was seeded into the lower chambers. After migration for 48 h, the upper surface of each membrane was cleaned with a cotton swab. Cells attached to the bottom surface of each membrane were stained with 0.1% crystal violet, imaged, and counted using a DMR inverted microscope (Leica Microsystems, Bensheim, Germany). Assays were performed in triplicate for three times. To determine the effect of CCL5 on astrocyte-stimulated RAW264.7 migration, astrocytes were stimulated with 0.5 μg/ml recombinant MIF following CCL5 siRNA interference for 24 h prior to a transwell assay. For M2 macrophage transition, RAW264.7 cells were treated with or without 20 ng/ml rat recombinant IL-13 for 2 days.</p>
</sec>
<sec id="Sec11">
<title>Sequencing of mRNA</title>
<p id="Par27">Total RNA of astrocytes following treatment with CD74-siRNA [<xref ref-type="bibr" rid="CR18">18</xref>] or scramble for 48 h, and then with 2.0 μg/ml recombinant MIF for 12 h and 24 h, respectively, was extracted using the mirVana miRNA Isolation Kit (Ambion, Austin, TX) according to the manufacturer’s instructions. They were then selected by RNA Purification Beads (Illumina, San Diego, CA) and undergone library construction and RNA-seq analysis. The library was constructed by using the Illumina TruSeq RNA sample Prep Kit v2 and sequenced by the Illumina HiSeq-2000 for 50 cycles. High-quality reads that passed the Illumina quality filters were kept for the sequence analysis.</p>
</sec>
<sec id="Sec12">
<title>Bioinformatics analysis</title>
<p id="Par28">Differentially expressed mRNA was designated in a criterion of greater than twofold or less than twofold change in comparison with control. Function of genes was annotated by Blastx against the NCBI database or the AGRIS database (<ext-link ext-link-type="uri" xlink:href="https://agris-knowledgebase.org/">https://agris-knowledgebase.org/</ext-link>) with <italic>E</italic> value threshold of 10<sup>−5</sup>. Gene ontology (GO) classification was obtained by WEGO (<ext-link ext-link-type="uri" xlink:href="http://wego.genomics.org.cn/">http://wego.genomics.org.cn/</ext-link>) via GO id annotated by Perl and R program. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways were assigned to the sequences using KEGG Automatic Annotation Server (KAAS) online. For all heatmaps, genes were clustered by Jensen-Shannon divergence.</p>
<p id="Par29">A reconstructed gene network was created using the Ingenuity Pathway Analysis (IPA) Software on the basis of differentially expressed genes (fold change &lt; 0.5 for downregulated genes at 12 h and 24 h following CD74 knockdown) to investigate their regulatory pathways and cellular functions [<xref ref-type="bibr" rid="CR26">26</xref>].</p>
</sec>
<sec id="Sec13">
<title>Behavioral tests</title>
<p id="Par30">The hindlimb locomotor function recovery was evaluated using the Basso, Beattie, and Bresnahan (BBB) locomotor scale as previously described [<xref ref-type="bibr" rid="CR27">27</xref>], after MIF or CCL5 treatment on 0, 7, 14, and 21 days after surgery. Three well-trained investigators who were blind to the study observed the behavior of rats for 5 min. The BBB score ranged from 0 to 21 according to the rating scale. Every rat had a BBB score of 21 before surgery. The BBB score would become 0 to 1 after a successful SCI.</p>
</sec>
<sec id="Sec14">
<title>Statistical analysis</title>
<p id="Par31">Statistical significance of differences between groups was analyzed by one-way analysis of variance (ANOVA) followed by Bonferroni’s post hoc comparisons tests with SPSS 15.0 (SPSS, Chicago, IL, USA). Normality and homoscedasticity of the data were verified before any statistical analysis using Levene’s test. Statistical significance was set at <italic>P</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="Sec15">
<title>Results</title>
<sec id="Sec16">
<title>MIF facilitated expression of chemokine CCL5 in the astrocytes of injured rat spinal cord</title>
<p id="Par32">To uncover the potential function of MIF in CCL5 expression, we firstly determined the protein levels of MIF and CCL5 in the contused spinal cord at different time points. Results revealed that CCL5 protein levels, assayed by ELISA, were synchronously increased with elevation of MIF assayed by Western blot (Fig. <xref ref-type="fig" rid="Fig1">1a–c</xref>). While treatment of 8 μl of 100 mM MIF inhibitor 4-IPP in the lesion site resulted in the remarkable reduction of CCL5 production (Fig. <xref ref-type="fig" rid="Fig1">1c</xref>). The data indicate that MIF efficiently regulates CCL5 production following SCI.<fig id="Fig1"><label>Fig. 1</label><caption><p>Determination of MIF and CCL5 expression following spinal cord injury. <bold>a</bold> Western blot analysis of MIF expression following spinal cord contusion at 0d, 1d, 4d, and 7d, respectively. <bold>b</bold> Quantification data as shown in <bold>a</bold>; quantities were normalized to endogenous β-actin. <bold>c</bold> CCL5 protein levels were assayed by ELISA for the injured cord at different time points with or without injection of 8 μl 4-IPP (100 mM) at the lesion sites. <bold>d</bold> Illustration of section sites showing immunostaining. <bold>e</bold> Immunostaining of CCL5 in the cross sections of rat contused spinal cord showed colocalization with GFAP-positive cells at 0d and 4d, with or without injection of 4-IPP, respectively. The rectangle indicates region magnified. Error bars represent the standard deviation (<italic>P</italic> &lt; 0.05). Scale bars, 100 μm</p></caption><graphic id="MO1" xlink:href="12974_2018_1297_Fig1_HTML"></graphic></fig></p>
<p id="Par33">Next, we sought to understand whether MIF-induced CCL5 expression was astrocyte-related. Immunostaining showed that CCL5 was exclusively colocalized with GFAP-positive, rather than with NeuN-, IBA-1-, or Olig2-positive cells (Additional file <xref ref-type="media" rid="MOESM1">1</xref>). CCL5 production was significantly increased in the GFAP-positive cells at 4 days following SCI (Fig. <xref ref-type="fig" rid="Fig1">1d, e</xref>). Whereas injection of 8 μl 4-IPP (100 mM) at the lesion site markedly decreased the expression of CCL5 in astrocytes (Fig. <xref ref-type="fig" rid="Fig1">1e</xref>). The results indicate that MIF is involved in regulation of CCL5 production in astrocytes after SCI.</p>
</sec>
<sec id="Sec17">
<title>Expression of CCL5 was regulated by MIF/CD74 axis in astrocytes</title>
<p id="Par34">MIF has been shown to interact with CD74 surface receptor, which forms a receptor complex with CXCR2 and CXCR4 to elicit intracellular signaling [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. To elucidate whether MIF/CD74 couple also exists in astrocytes, the rat astrocytes were firstly isolated and cultured with purity more than 95% (Fig. <xref ref-type="fig" rid="Fig2">2a, b</xref>). Co-immunoprecipitation was then carried out using anti-His or anti-CD74 antibody. As shown in Fig. <xref ref-type="fig" rid="Fig2">2c</xref>, recombinant His-tagged MIF was present in the CD74-associated complexes immunoprecipitated with anti-CD74 antibody, so was CD74 in the His-associated complexes. The results indicate that MIF can bind with CD74 surface receptor of astrocytes.<fig id="Fig2"><label>Fig. 2</label><caption><p>Binding assay of MIF with CD74 receptor in the primary astrocytes. <bold>a</bold> Purified primary astrocytes stained with GFAP and Hoechst 33342. <bold>b</bold> Statistical analysis of primary astrocyte purity. <bold>c</bold> Immunoprecipitation using anti-His or anti-CD74 antibody and detection of the components of the rMIF- or CD74-associated complexes with anti-CD74 or anti-His antibody. M marker, A/G protein A/G magnetic beads. Scale bars, 50 μm</p></caption><graphic id="MO2" xlink:href="12974_2018_1297_Fig2_HTML"></graphic></fig></p>
<p id="Par35">To understand whether CCL5 expression is under regulation of MIF/CD74 axis, we performed transcriptome analysis on primary astrocytes interfered by effective CD74 siRNA or scramble for 48 h [<xref ref-type="bibr" rid="CR18">18</xref>], followed by stimulation with 2.0 μg/ml recombinant MIF protein for 12 and 24 h, respectively. A total of 456 and 255 differentially expressed genes (DEGs; siRNA versus scramble) were identified at the two time points, with defined criteria of <italic>P</italic> &lt; 0.05 and a greater than twofold or less than twofold change (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). We further integrated the DEGs and characterized 175 functional genes (Fig. <xref ref-type="fig" rid="Fig3">3a</xref>). KEGG pathway enrichment analysis of these integrated DEGs revealed that chemotaxis signaling, inflammatory responses, and related ERK1/2 cascades were included in the significantly enriched functional pathway (Fig. <xref ref-type="fig" rid="Fig3">3b</xref>). Such pathways account for 48 of all 175 DEGs.<fig id="Fig3"><label>Fig. 3</label><caption><p>Functional annotations of DEGs and the inferred gene network in the astrocytes. <bold>a</bold> Integration of DEGs following knockdown of CD74 receptor for 48 h and then treated with 2 μg/ml recombinant rat MIF at 12 h and 24 h, respectively. <bold>b</bold> Most significantly enriched groups for the integrated DEGs relating to pathways. <bold>c</bold> A reconstructed gene network was created using the Ingenuity Pathway Analysis (IPA) Software on the basis of integrated DEGs</p></caption><graphic id="MO3" xlink:href="12974_2018_1297_Fig3_HTML"></graphic></fig></p>
<p id="Par36">To shed light on the mechanism of molecular changes following blockade of CD74, the Ingenuity Pathway Analysis (IPA) was performed for the DEGs integrated at 12 and 24 h. The weight value of each gene in the network was calculated, representing the effect of MIF on the downstream targets. A reconstructed gene network showed that CCL5 and CCL12 with the highest weight value were highlighted as the important chemokines regulated by MIF/CD74 axis (Fig. <xref ref-type="fig" rid="Fig3">3c</xref>). As CCL12 has only been described in mice, we thus focus our attention on regulation of CCL5 [<xref ref-type="bibr" rid="CR30">30</xref>].</p>
<p id="Par37">All the genes displayed dynamic alteration following CD74 siRNA knockdown, as shown by the heatmap and cluster dendrogram (Fig. <xref ref-type="fig" rid="Fig4">4</xref>).<fig id="Fig4"><label>Fig. 4</label><caption><p>Heatmap and cluster dendrogram of integrated DEGs following knockdown of CD74 receptor for 48 h and stimulated astrocytes with 2 μg/ml recombinant rat MIF for 12 h and 24 h, respectively. The color scale shown at the top illustrates the relative expression level of the indicated mRNA across all samples: red denotes expression &gt; 0 and green denotes expression &lt; 0</p></caption><graphic id="MO4" xlink:href="12974_2018_1297_Fig4_HTML"></graphic></fig></p>
</sec>
<sec id="Sec18">
<title>MIF inhibitor attenuated CCL5 expression of astrocytes in vitro</title>
<p id="Par38">To substantiate inference drawn from transcriptome analysis, the primary astrocytes were stimulated with recombinant MIF protein at a concentration of 0–2.5 μg/ml for 24 h, with or without addition of 100 μM 4-IPP. ELISA results showed that MIF was able to facilitate CCL5 production of astrocytes in a concentration-dependent manner. Treatment of astrocytes with 0.5 μg/ml MIF led to remarkable synthesis and secretion of CCL5, while addition of 100 μM 4-IPP to the culture significantly reduced CCL5 protein levels in both supernatant and lysate (Fig. <xref ref-type="fig" rid="Fig5">5a, b</xref>). It was interesting to note that 4-IPP even decreased protein levels of CCL5 in lysate in the absence of MIF stimulation, probably involved in inhibition of endogenous CCL5 expression. These results indicate that MIF directly induces the CCL5 expression in astrocytes.<fig id="Fig5"><label>Fig. 5</label><caption><p>Examination of CCL5 production in astrocytes following stimuli with gradient recombinant MIF in the presence of 4-IPP. Cell supernatants (<bold>a</bold>) and lysates (<bold>b</bold>) were tested by ELISA for the chemokine CCL5, following astrocyte treatment with 0–2.5 μg/ml recombinant MIF for 24 h in the presence of 100 μM 4-IPP. Experiments were performed in triplicates. Error bars represent the standard deviation (<italic>P</italic> &lt; 0.05)</p></caption><graphic id="MO5" xlink:href="12974_2018_1297_Fig5_HTML"></graphic></fig></p>
</sec>
<sec id="Sec19">
<title>MIF promoted CCL5 production of astrocytes through JNK signaling</title>
<p id="Par39">Several virus, cytokines, or natural chemicals are able to induce CCL5 production in immune cells or glial cells through mitogen-activated protein kinase (MAPK) and NFκB signaling pathways [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>]. To clarify the relevant pathway through which MIF facilitates CCL5 production of astrocytes, we interfered with the signal pathway through knockdown of CD74 receptor. The siRNA oligonucleotide (siRNA2) with nearly 60% knockdown efficiency of CD74 was chosen for the next experiments (Fig. <xref ref-type="fig" rid="Fig6">6a</xref>). CD74 receptor of astrocyte was knocked down by siRNA2 for 48 h, followed by the cell treatment with 0.5 μg/ml recombinant MIF protein for 15 min, 30 min, and 60 min, respectively. Determination of ERK, P38, and c-Jun N-terminal kinase (JNK) phosphorylation demonstrated that the phosphorylated level of these kinases and NFkB activity were significantly reduced in astrocytes (Fig. <xref ref-type="fig" rid="Fig6">6b, c</xref>). However, CCL5 production in the cells stimulated with recombinant MIF for 24 h was exclusively attenuated by treatment of JNK (SP600125), rather than by ERK (PD98059) or P38 (SB203580) inhibitor (Fig. <xref ref-type="fig" rid="Fig6">6d</xref>). These data indicate that MIF induces CCL5 production of astrocytes through JNK signaling.<fig id="Fig6"><label>Fig. 6</label><caption><p>Determination of intracellular signaling associated with regulation of CCL5 expression. <bold>a</bold> Interference efficiency of three siRNA oligonucleotides for CD74 was measured by RT-PCR, and siRNA2 was used for the knockdown experiments. <bold>b</bold> Western blot analysis of pERK, p-P38, pJNK, and p65NFκB following astrocytes treated with siRNA oligonucleotides or scramble for 48 h and then with 2 μg/ml recombinant MIF for 15 min, 30 min, and 60 min, respectively. <bold>c</bold> Quantification data as shown in <bold>a</bold>. <bold>d</bold> Cell supernatants and lysates were tested by ELISA for the production of CCL5 following astrocyte treatment with inhibitor of ERK (PD98059), P38 (SB203580), or JNK (SP600125). Experiments were performed in triplicates. Error bars represent the standard deviation (<italic>P</italic> &lt; 0.05)</p></caption><graphic id="MO6" xlink:href="12974_2018_1297_Fig6_HTML"></graphic></fig></p>
</sec>
<sec id="Sec20">
<title>CCL5 primarily potentiated migration of IL-13-treated macrophages</title>
<p id="Par40">Chemokines are known to be essential for macrophage migration towards the site of injury [<xref ref-type="bibr" rid="CR33">33</xref>]. To elucidate chemotactic function of astrocyte-released CCL5, we performed transwell assay to observe migration of macrophage RAW 264.7 cells in the presence of astrocytes with or without siRNA knockdown of CCL5 expression (Fig. <xref ref-type="fig" rid="Fig7">7a</xref>). Of three siRNA oligonucleotides, siRNA1 with a 72% CCL5 knockdown efficiency was selected (Fig. <xref ref-type="fig" rid="Fig7">7b</xref>). Astrocytes were stimulated with 0.5 μg/ml recombinant MIF following CCL5 siRNA1 interference for 24 h prior to macrophage migration for 48 h. Addition of recombinant MIF promoted a moderate migration of the unmodified macrophages, and such effect could be slightly attenuated by CCL5 siRNA1 interference, suggesting other factors in action (Fig. <xref ref-type="fig" rid="Fig7">7c, d</xref>). However, when the macrophages were incubated in 20 ng/ml recombinant rat IL-13 protein for 2 days, a transition from M1- to M2-phenotype identified by iNOS and Arginase1 expression [<xref ref-type="bibr" rid="CR34">34</xref>], MIF was found to significantly facilitate the migration of these IL-13-modified cells (Fig. <xref ref-type="fig" rid="Fig7">7c–e</xref>). CCL5 knockdown of astrocytes remarkably reduced migratory cell numbers (Fig. <xref ref-type="fig" rid="Fig7">7c, d</xref>). The data indicate that CCL5 produced by astrocytes is primarily involved in promoting migration of M2 macrophages.<fig id="Fig7"><label>Fig. 7</label><caption><p>Effects of CCL5 on macrophage migration in vitro. <bold>a</bold> Transwell assay using cell co-culture model. <bold>b</bold> Interference efficiency of three siRNA oligonucleotides for CCL5 was measured by RT-PCR, and siRNA1 was used for the knockdown experiments. <bold>c</bold> Migration assay of macrophages co-cultured with astrocytes with or without knockdown of CCL5. Astrocytes were stimulated with 0.5 μg/ml recombinant MIF following CCL5 siRNA interference for 24 h prior to macrophage migration for 48 h. For a transition of macrophages from M1- to M2-phenotype, the cells were incubated in 20 ng/ml recombinant rat IL-13 protein for 2 days. <bold>d</bold> Quantification data as shown in <bold>c</bold>. <bold>e</bold> The expression of M1 and M2 macrophage markers, <italic>iNOS</italic> and <italic>Arginase1</italic>, was determined by RT-PCR. Quantities were normalized to endogenous β-actin. Error bars represent the standard deviation. *<italic>P</italic> &lt; 0.05, <sup>#</sup><italic>P</italic> &lt; 0.05. Scale bars, 100 μm</p></caption><graphic id="MO7" xlink:href="12974_2018_1297_Fig7_HTML"></graphic></fig></p>
<p id="Par41">To observe the effects of MIF-induced CCL5 on migration of microglia in vivo, we detected the temporal distribution of microglia following spinal cord injury. Immunostaining with IBA-1 antibody displayed that SCI resulted in significant accumulation of microglia in the injured cord, with a peak at 4 days (Fig. <xref ref-type="fig" rid="Fig8">8a, c</xref>). Injection of 8 μl of 100 μg/ml recombinant MIF or 4 μl of 100 μg/ml recombinant CCL5 protein at the lesion site aggravated the amounts of IBA-1-positive cells. However, treatment with 8 μl of 100 mM 4-IPP resulted in a significant reduction of microglia migration (Fig. <xref ref-type="fig" rid="Fig8">8a–e</xref>).<fig id="Fig8"><label>Fig. 8</label><caption><p>Immunostaining of microglia after rat spinal cord injury. <bold>a</bold> Immunostaining of IBA-1-positive cells following spinal cord contusion at 0d, 1d, 4d, and 7d, following injection of 8 μl of 100 μg/ml recombinant MIF, 4 μl of 100 μg/ml recombinant CCL5, or 8 μl of 100 mM 4-IPP, respectively. The rectangle indicates region magnified. <bold>b</bold> Illustration of section sites for immunostaining in the contused cord. <bold>c</bold>–<bold>e</bold> Statistic analysis of IBA-1-positive cells in <bold>a</bold> from 15 fields each. <bold>f</bold> BBB scores for hindlimb motor function in each group at different time points. Six rats/group were evaluated at 0d after injury, and four rats in the vehicle-treated group and three rats in the 4-IPP- or rMIF-treated group were evaluated from 7 days onwards due to sacrifice for immunostainings following significant difference (<italic>n</italic> = 3–6). Error bars represent the standard deviation (<italic>P</italic> &lt; 0.05). Scale bars, 500 μm in section, and 100 μm in magnification</p></caption><graphic id="MO8" xlink:href="12974_2018_1297_Fig8_HTML"></graphic></fig></p>
<p id="Par42">To assess the influences of MIF or CCL5 on the functional recovery, BBB scores were measured during 3 weeks after the spinal cord injury. Injection of 8 μl of 100 μg/ml recombinant MIF or 4 μl of 100 μg/ml recombinant CCL5 significantly aggravated the hindlimb motor function compared with the vehicle. However, treatment of 4-IPP demonstrated a significant improvement (Fig. <xref ref-type="fig" rid="Fig8">8f</xref>). The results indicate that MIF-induced CCL5 release from astrocytes is sufficient to potentiate migration of microglia in the injured spinal cord, which is involved in the neuropathogenesis.</p>
</sec>
</sec>
<sec id="Sec21">
<title>Discussion</title>
<p id="Par43">Emerging evidence has shown that MIF plays a role as a neuroimmuno-modulator in the CNS. Multiple cell types in CNS express this protein, such as microglia, fibroblasts, pituitary cells, endothelial cells, neurons, and neural stem cell progenitors [<xref ref-type="bibr" rid="CR35">35</xref>]. Aberrant expression of MIF has shown to result in several pathological diseases of the CNS including Alzheimer’s disease, autism spectrum disorders, encephalomyelitis, and tumorigenesis [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR38">38</xref>]. In the acute phase of spinal cord injury, MIF contributes to neuropathological impairments through promoting neuronal death and inflammatory activation [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. It has been thought that microglia and other leukocytes are main resources of inflammatory cytokines in response to MIF stimuli [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. However, inflammatory signal pathway in astrocytes can also be activated by MIF through phosphorylation of ERK [<xref ref-type="bibr" rid="CR18">18</xref>]. Here, we revealed a novel role of MIF in facilitating CCL5 production of astrocytes through activation of JNK, suggesting that MIF-induced releases of cytokines and chemokines are associated with multiple intracellular signals. Previous reports have shown that M1 and M2 macrophages populate the injury site with relatively equal distribution within the first week after SCI [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. MIF-induced CCL5 release from astrocytes is primarily implicated in the cell events of M2 macrophages.</p>
<p id="Par44">MIF regulates distinct intracellular signaling in a cell type-dependent way. This factor has been shown to interact with CD74 receptor on macrophages, astrocytes, fibroblasts, tumor cells, or B lymphocytes, resulting in sustained activation of ERK1/2 kinase that brings in various effects [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. Activation of MIF on JNK signaling has been identified in fibroblasts and T cell lines, in which phosphorylation of JNK is regulated by kinases PI3K and SRC [<xref ref-type="bibr" rid="CR43">43</xref>]. In the CD11b<sup>+</sup>Gr-1<sup>+</sup> myeloid cells, MIF is capable of potentiating chemotaxis, differentiation, and pro-angiogenesis through activation of p38/MAPK and PI3K/AKT signal pathways [<xref ref-type="bibr" rid="CR44">44</xref>]. In the present study, we demonstrated that MIF/CD74 axis was able to regulate activities of ERK, P38, and JNK in astrocytes, suggesting a multifunctionality of MIF on astrocytes.</p>
<p id="Par45">CCL5 induces the migration and recruitment of a wide variety of cells including T cells, dendritic cells, NK cells, eosinophils, basophils, mast cells, and endothelial progenitor cells [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. Interestingly, its effects on chemotaxis of macrophages are found to have tissue specificity. For examples, CCL5 is involved in recruitment and survival of macrophages in human adipose tissue [<xref ref-type="bibr" rid="CR46">46</xref>] and in accumulation of macrophage in the kidney, liver, and peripheral nervous tissues [<xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref>]. In the CNS, however, the role of CCL5 in recruitment of inflammatory cells is controversial. In the hippocampi of mice, CCL5 has been shown to be not critical for accumulation of microglia [<xref ref-type="bibr" rid="CR2">2</xref>]. We revealed that CCL5 primarily facilitates migration of IL-13-incubated macrophages, in consistency with that of IL-4-treated M2 macrophages [<xref ref-type="bibr" rid="CR10">10</xref>]. The discrepancy may be attributed to the distinct phenotypes of microglia, either a greater recruitment of monocyte-derived macrophages in SCI or the alternative activation status stimulated by specific milieu [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR50">50</xref>]. These results indicate that CCL5 alternatively facilitates accumulation of macrophages, depending on the cell subtype.</p>
<p id="Par46">CCL5 is inducibly produced by invading pathogens or proinflammatory cytokines through activation of intracellular signals in a cell-specific manner [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. HIV-1 induces CCL5 primarily by transcriptional activation, while bacterial lipopolysaccharide (LPS) induces CCL5 in microglia via activation of TLR4 receptor [<xref ref-type="bibr" rid="CR51">51</xref>]. Cytokine IL-1 is able to induce expression of CCL5 in astrocytes through phosphorylation of P38 or JNK, but not of ERK [<xref ref-type="bibr" rid="CR31">31</xref>]. In the present study, we displayed that MIF induced CCL5 production in astrocytes through activation of JNK signaling. These results indicate that the regulatory mechanism of CCL5 expression is differential in different cell types.</p>
</sec>
<sec id="Sec22">
<title>Conclusions</title>
<p id="Par47">Protein levels of MIF were increased in response to SCI, which interacted with CD74 receptor of astrocytes to promote CCL5 production through activation of JNK. CCL5 in turn facilitated migration of macrophages to the lesion site, which affected repair of injured spinal cord.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional file</title>
<sec id="Sec23">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12974_2018_1297_MOESM1_ESM.pdf"><label>Additional file 1:</label><caption><p><bold>Figure S1.</bold> Determination of CCL5 colocalization with NeuN-, IBA-1-, or Olig2-positive cells following spinal cord contusion at 4 days. (PDF 397 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>ANOVA</term>
<def>
<p id="Par5">Analysis of variance</p>
</def>
</def-item>
<def-item>
<term>MIF</term>
<def>
<p id="Par6">Macrophage migration inhibitory factor</p>
</def>
</def-item>
<def-item>
<term>CCL5</term>
<def>
<p id="Par7">Chemokine (C-C motif) ligand 5</p>
</def>
</def-item>
<def-item>
<term>PBS</term>
<def>
<p id="Par8">Phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term>MS</term>
<def>
<p id="Par9">Multiple sclerosis</p>
</def>
</def-item>
<def-item>
<term>SCI</term>
<def>
<p id="Par10">Spinal cord injury</p>
</def>
</def-item>
<def-item>
<term>GFAP</term>
<def>
<p id="Par11">Glial fibrillary acid protein</p>
</def>
</def-item>
<def-item>
<term>ELISA</term>
<def>
<p id="Par12">Enzyme-linked immunosorbent assay</p>
</def>
</def-item>
<def-item>
<term>KEGG</term>
<def>
<p id="Par13">Kyoto Encyclopedia of Genes and Genomes</p>
</def>
</def-item>
<def-item>
<term>IPA</term>
<def>
<p id="Par14">Ingenuity Pathway Analysis</p>
</def>
</def-item>
<def-item>
<term>DEGs</term>
<def>
<p id="Par15">Differentially expressed genes</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<sec id="FPar1">
<title>Funding</title>
<p id="Par48">This study was supported by the the National Key Research and Development Program of China (2018YFC1105603), and the National Natural Science Foundation of China (No. 31471011; 31640042; 31871211).</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par49">The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>YjunW and AG designed this work. YjunW wrote the paper. YZ, YjunW, and WG performed the experiments. YZ, YjunW, WG, AG, ZZ, YH, YjieW, XZ, WW, ND, KY, ZG, and TS analyzed the data. AG joined discussions. All authors have approved the final version of the manuscript and have agreed to be accountable for all aspects of the work regarding questions related to the accuracy or integrity of any part of the work.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval</title>
<p>All animal experiments were approved by the Animal Care and Use Committee of Nantong University and the Jiangsu Province Animal Care Ethics Committee.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gadani</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Lukens</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kipnis</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Dealing with danger in the CNS: the response of the immune system to injury</article-title>
<source/>Neuron
          <year>2015</year>
<volume>87</volume>
<fpage>47</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuron.2015.05.019</pub-id>
<pub-id pub-id-type="pmid">26139369</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babcock</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Kuziel</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Rivest</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Owens</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS</article-title>
<source/>J Neurosci
          <year>2003</year>
<volume>23</volume>
<fpage>7922</fpage>
<lpage>7930</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-21-07922.2003</pub-id>
<pub-id pub-id-type="pmid">12944523</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hausmann</surname>
<given-names>ON</given-names>
</name>
</person-group>
<article-title>Post-traumatic inflammation following spinal cord injury</article-title>
<source/>Spinal Cord
          <year>2003</year>
<volume>41</volume>
<fpage>369</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1038/sj.sc.3101483</pub-id>
<pub-id pub-id-type="pmid">12815368</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossi</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Astrocyte physiopathology: at the crossroads of intercellular networking, inflammation and cell death</article-title>
<source/>Prog Neurobiol
          <year>2015</year>
<volume>130</volume>
<fpage>86</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.04.003</pub-id>
<pub-id pub-id-type="pmid">25930681</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luo</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Berman</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Fischer</surname>
<given-names>FR</given-names>
</name>
<name>
<surname>Abromson-Leeman</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kuziel</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Gerard</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dorf</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes</article-title>
<source/>Glia
          <year>2002</year>
<volume>39</volume>
<fpage>19</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1002/glia.10079</pub-id>
<pub-id pub-id-type="pmid">12112372</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meeuwsen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Persoon-Deen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bsibsi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ravid</surname>
<given-names>R</given-names>
</name>
<name>
<surname>van Noort</surname>
<given-names>JM</given-names>
</name>
</person-group>
<article-title>Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli</article-title>
<source/>Glia
          <year>2003</year>
<volume>43</volume>
<fpage>243</fpage>
<lpage>253</lpage>
<pub-id pub-id-type="doi">10.1002/glia.10259</pub-id>
<pub-id pub-id-type="pmid">12898703</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carpentier</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Begolka</surname>
<given-names>WS</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Elhofy</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Karpus</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>SD</given-names>
</name>
</person-group>
<article-title>Differential activation of astrocytes by innate and adaptive immune stimuli</article-title>
<source/>Glia
          <year>2005</year>
<volume>49</volume>
<fpage>360</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1002/glia.20117</pub-id>
<pub-id pub-id-type="pmid">15538753</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Falsig</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Porzgen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lund</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schrattenholz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leist</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function</article-title>
<source/>J Neurochem
          <year>2006</year>
<volume>96</volume>
<fpage>893</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03622.x</pub-id>
<pub-id pub-id-type="pmid">16405499</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Guabiraba</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Russo</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Targeting CCL5 in inflammation</article-title>
<source/>Expert Opin Ther Targets
          <year>2013</year>
<volume>17</volume>
<fpage>1439</fpage>
<lpage>1460</lpage>
<pub-id pub-id-type="doi">10.1517/14728222.2013.837886</pub-id>
<pub-id pub-id-type="pmid">24090198</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogel</surname>
<given-names>DY</given-names>
</name>
<name>
<surname>Heijnen</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>Breur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Tool</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dijkstra</surname>
<given-names>CD</given-names>
</name>
</person-group>
<article-title>Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation</article-title>
<source/>J Neuroinflammation
          <year>2014</year>
<volume>11</volume>
<fpage>23</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-11-23</pub-id>
<pub-id pub-id-type="pmid">24485070</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glabinski</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>VK</given-names>
</name>
<name>
<surname>Ransohoff</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis</article-title>
<source/>Neuroimmunomodulation
          <year>1998</year>
<volume>5</volume>
<fpage>166</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1159/000026333</pub-id>
<pub-id pub-id-type="pmid">9730682</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oh</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Schwiebert</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Benveniste</surname>
<given-names>EN</given-names>
</name>
</person-group>
<article-title>Cytokine regulation of CC and CXC chemokine expression by human astrocytes</article-title>
<source/>J Neuro-Oncol
          <year>1999</year>
<volume>5</volume>
<fpage>82</fpage>
<lpage>94</lpage>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calandra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Roger</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Macrophage migration inhibitory factor: a regulator of innate immunity</article-title>
<source/>Nat Rev Immunol
          <year>2003</year>
<volume>3</volume>
<fpage>791</fpage>
<lpage>800</lpage>
<pub-id pub-id-type="doi">10.1038/nri1200</pub-id>
<pub-id pub-id-type="pmid">14502271</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chalimoniuk</surname>
<given-names>M</given-names>
</name>
<name>
<surname>King-Pospisil</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Metz</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Toborek</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Macrophage migration inhibitory factor induces cell death and decreases neuronal nitric oxide expression in spinal cord neurons</article-title>
<source/>Neuroscience
          <year>2006</year>
<volume>139</volume>
<fpage>1117</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.12.056</pub-id>
<pub-id pub-id-type="pmid">16504406</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ogata</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nishihira</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nagashima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tashiro</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization</article-title>
<source/>Neurosci Lett
          <year>1998</year>
<volume>246</volume>
<fpage>173</fpage>
<lpage>177</lpage>
<pub-id pub-id-type="doi">10.1016/S0304-3940(98)00203-1</pub-id>
<pub-id pub-id-type="pmid">9792620</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishio</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koshizuka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishihira</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Moriya</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats</article-title>
<source/>Acta Neuropathol
          <year>2004</year>
<volume>108</volume>
<fpage>31</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-004-0853-z</pub-id>
<pub-id pub-id-type="pmid">15067555</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishio</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Koda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hashimoto</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Koshizuka</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Yoshinaga</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Onodera</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Nishihira</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Okawa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Deletion of macrophage migration inhibitory factor attenuates neuronal death and promotes functional recovery after compression-induced spinal cord injury in mice</article-title>
<source/>Acta Neuropathol
          <year>2009</year>
<volume>117</volume>
<fpage>321</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-008-0476-x</pub-id>
<pub-id pub-id-type="pmid">19125256</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Macrophage migration inhibitory factor activates inflammatory responses of astrocytes through interaction with CD74 receptor</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<fpage>2719</fpage>
<lpage>2730</lpage>
<pub-id pub-id-type="pmid">27926507</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Benveniste</surname>
<given-names>EN</given-names>
</name>
</person-group>
<article-title>Immune function of astrocytes</article-title>
<source/>Glia
          <year>2001</year>
<volume>36</volume>
<fpage>180</fpage>
<lpage>190</lpage>
<pub-id pub-id-type="doi">10.1002/glia.1107</pub-id>
<pub-id pub-id-type="pmid">11596126</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Farina</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Aloisi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Meinl</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Astrocytes are active players in cerebral innate immunity</article-title>
<source/>Trends Immunol
          <year>2007</year>
<volume>28</volume>
<fpage>138</fpage>
<lpage>145</lpage>
<pub-id pub-id-type="doi">10.1016/j.it.2007.01.005</pub-id>
<pub-id pub-id-type="pmid">17276138</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Hung</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Chiu</surname>
<given-names>WT</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>YY</given-names>
</name>
<name>
<surname>Tsai</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>YH</given-names>
</name>
</person-group>
<article-title>Curcumin enhances neuronal survival in N-methyl-d-aspartic acid toxicity by inducing RANTES expression in astrocytes via PI-3K and MAPK signaling pathways</article-title>
<source/>Prog Neuro-Psychopharmacol Biol Psychiatry
          <year>2011</year>
<volume>35</volume>
<fpage>931</fpage>
<lpage>938</lpage>
<pub-id pub-id-type="doi">10.1016/j.pnpbp.2010.12.022</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gangwani</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Noel</surname>
<given-names>RJ</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Shah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rivera-Amill</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Human immunodeficiency virus type 1 viral protein R (Vpr) induces CCL5 expression in astrocytes via PI3K and MAPK signaling pathways</article-title>
<source/>J Neuroinflammation
          <year>2013</year>
<volume>10</volume>
<fpage>136</fpage>
<pub-id pub-id-type="doi">10.1186/1742-2094-10-136</pub-id>
<pub-id pub-id-type="pmid">24225433</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chehrehasa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cobcroft</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>YW</given-names>
</name>
<name>
<surname>Mackay-Sim</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goss</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>An acute growth factor treatment that preserves function after spinal cord contusion injury</article-title>
<source/>J Neurotrauma
          <year>2014</year>
<volume>31</volume>
<fpage>1807</fpage>
<lpage>1813</lpage>
<pub-id pub-id-type="doi">10.1089/neu.2013.3294</pub-id>
<pub-id pub-id-type="pmid">24836764</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>PERK pathway is involved in oxygen-glucose-serum deprivation-induced NF-kB activation via ROS generation in spinal cord astrocytes</article-title>
<source/>Biochem Biophys Res Commun
          <year>2015</year>
<volume>467</volume>
<fpage>197</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbrc.2015.10.007</pub-id>
<pub-id pub-id-type="pmid">26454173</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Niu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Chitosan degradation products facilitate peripheral nerve regeneration by improving macrophage-constructed microenvironments</article-title>
<source/>Biomaterials
          <year>2017</year>
<volume>134</volume>
<fpage>64</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1016/j.biomaterials.2017.02.026</pub-id>
<pub-id pub-id-type="pmid">28456077</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kramer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>J</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Tugendreich</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Causal analysis approaches in Ingenuity Pathway Analysis</article-title>
<source/>Bioinformatics
          <year>2014</year>
<volume>30</volume>
<fpage>523</fpage>
<lpage>530</lpage>
<pub-id pub-id-type="doi">10.1093/bioinformatics/btt703</pub-id>
<pub-id pub-id-type="pmid">24336805</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Basso</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Beattie</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Bresnahan</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>A sensitive and reliable locomotor rating scale for open field testing in rats</article-title>
<source/>J Neurotrauma
          <year>1995</year>
<volume>12</volume>
<fpage>1</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1089/neu.1995.12.1</pub-id>
<pub-id pub-id-type="pmid">7783230</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Metz</surname>
<given-names>CN</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baugh</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Delohery</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bucala</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>MIF signal transduction initiated by binding to CD74</article-title>
<source/>J Exp Med
          <year>2003</year>
<volume>197</volume>
<fpage>1467</fpage>
<lpage>1476</lpage>
<pub-id pub-id-type="doi">10.1084/jem.20030286</pub-id>
<pub-id pub-id-type="pmid">12782713</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krohn</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lue</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gregory</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Zernecke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koenen</surname>
<given-names>RR</given-names>
</name>
<name>
<surname>Dewor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Georgiev</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Schober</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment</article-title>
<source/>Nat Med
          <year>2007</year>
<volume>13</volume>
<fpage>587</fpage>
<lpage>596</lpage>
<pub-id pub-id-type="doi">10.1038/nm1567</pub-id>
<pub-id pub-id-type="pmid">17435771</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<mixed-citation publication-type="other">DeLeon-Pennell KY, Iyer RP, Ero OK, Cates CA, Flynn ER, Cannon PL, Jung M, Shannon D, Garrett MR, Buchanan W, et al. Periodontal-induced chronic inflammation triggers macrophage secretion of Ccl12 to inhibit fibroblast-mediated cardiac wound healing. JCI Insight. 2017;2:14.</mixed-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Brosnan</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SC</given-names>
</name>
</person-group>
<article-title>Regulation of RANTES/CCL5 expression in human astrocytes by interleukin-1 and interferon-beta</article-title>
<source/>J Neurochem
          <year>2004</year>
<volume>90</volume>
<fpage>297</fpage>
<lpage>308</lpage>
<pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02487.x</pub-id>
<pub-id pub-id-type="pmid">15228586</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nakamichi</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Saiki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Sawada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Takayama-Ito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yamamuro</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kurane</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Rabies virus-induced activation of mitogen-activated protein kinase and NF-kappaB signaling pathways regulates expression of CXC and CC chemokine ligands in microglia</article-title>
<source/>J Virol
          <year>2005</year>
<volume>79</volume>
<fpage>11801</fpage>
<lpage>11812</lpage>
<pub-id pub-id-type="doi">10.1128/JVI.79.18.11801-11812.2005</pub-id>
<pub-id pub-id-type="pmid">16140757</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanuma</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Sakuma</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Sasaki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis</article-title>
<source/>Acta Neuropathol
          <year>2006</year>
<volume>112</volume>
<fpage>195</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1007/s00401-006-0083-7</pub-id>
<pub-id pub-id-type="pmid">16733654</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Biswas</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Gilroy</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Goerdt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hamilton</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Ivashkiv</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Lawrence</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Macrophage activation and polarization: nomenclature and experimental guidelines</article-title>
<source/>Immunity
          <year>2014</year>
<volume>41</volume>
<fpage>14</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.008</pub-id>
<pub-id pub-id-type="pmid">25035950</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leyton-Jaimes</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kahn</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Israelson</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Macrophage migration inhibitory factor: a multifaceted cytokine implicated in multiple neurological diseases</article-title>
<source/>Exp Neurol
          <year>2018</year>
<volume>301</volume>
<fpage>83</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2017.06.021</pub-id>
<pub-id pub-id-type="pmid">28679106</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bacher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schrader</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kuschela</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Gemsa</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Waeber</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumor cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme</article-title>
<source/>Am J Pathol
          <year>2003</year>
<volume>162</volume>
<fpage>11</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/S0002-9440(10)63793-5</pub-id>
<pub-id pub-id-type="pmid">12507885</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>An</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MA</given-names>
</name>
</person-group>
<article-title>Identification of gliotropic factors that induce human stem cell migration to malignant tumor</article-title>
<source/>J Proteome Res
          <year>2009</year>
<volume>8</volume>
<fpage>2873</fpage>
<lpage>2881</lpage>
<pub-id pub-id-type="doi">10.1021/pr900020q</pub-id>
<pub-id pub-id-type="pmid">19351187</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benedek</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Meza-Romero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jordan</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Keenlyside</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Offner</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vandenbark</surname>
<given-names>AA</given-names>
</name>
</person-group>
<article-title>HLA-DRalpha1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection</article-title>
<source/>J Neuroinflammation
          <year>2015</year>
<volume>12</volume>
<fpage>123</fpage>
<pub-id pub-id-type="doi">10.1186/s12974-015-0342-4</pub-id>
<pub-id pub-id-type="pmid">26104759</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calandra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Bucala</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor</article-title>
<source/>J Exp Med
          <year>1994</year>
<volume>179</volume>
<fpage>1895</fpage>
<lpage>1902</lpage>
<pub-id pub-id-type="doi">10.1084/jem.179.6.1895</pub-id>
<pub-id pub-id-type="pmid">8195715</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kroner</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Repertoire of microglial and macrophage responses after spinal cord injury</article-title>
<source/>Nat Rev Neurosci
          <year>2011</year>
<volume>12</volume>
<fpage>388</fpage>
<lpage>399</lpage>
<pub-id pub-id-type="doi">10.1038/nrn3053</pub-id>
<pub-id pub-id-type="pmid">21673720</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thawer</surname>
<given-names>SG</given-names>
</name>
<name>
<surname>Mawhinney</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Chadwick</surname>
<given-names>K</given-names>
</name>
<name>
<surname>de Chickera</surname>
<given-names>SN</given-names>
</name>
<name>
<surname>Weaver</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dekaban</surname>
<given-names>GA</given-names>
</name>
</person-group>
<article-title>Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model</article-title>
<source/>J Neuroimmunol
          <year>2013</year>
<volume>261</volume>
<fpage>7</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1016/j.jneuroim.2013.04.008</pub-id>
<pub-id pub-id-type="pmid">23711349</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J</given-names>
</name>
<name>
<surname>McDonald</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Lolis</surname>
<given-names>E</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex</article-title>
<source/>Immunity
          <year>2006</year>
<volume>25</volume>
<fpage>595</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.020</pub-id>
<pub-id pub-id-type="pmid">17045821</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lue</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Dewor</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Leng</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bucala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bernhagen</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Activation of the JNK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on CXCR4 and CD74</article-title>
<source/>Cell Signal
          <year>2011</year>
<volume>23</volume>
<fpage>135</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2010.08.013</pub-id>
<pub-id pub-id-type="pmid">20807568</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lei</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>HIF-alpha/MIF and NF-kappaB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC</article-title>
<source/>Neoplasia
          <year>2014</year>
<volume>16</volume>
<fpage>168</fpage>
<lpage>179</lpage>
<pub-id pub-id-type="doi">10.1593/neo.132034</pub-id>
<pub-id pub-id-type="pmid">24709424</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ishida</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuninaka</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Inui</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Matsushima</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mukaida</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing</article-title>
<source/>J Clin Invest
          <year>2012</year>
<volume>122</volume>
<fpage>711</fpage>
<lpage>721</lpage>
<pub-id pub-id-type="doi">10.1172/JCI43027</pub-id>
<pub-id pub-id-type="pmid">22214846</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keophiphath</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rouault</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Divoux</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Clement</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Lacasa</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>CCL5 promotes macrophage recruitment and survival in human adipose tissue</article-title>
<source/>Arterioscler Thromb Vasc Biol
          <year>2010</year>
<volume>30</volume>
<fpage>39</fpage>
<lpage>45</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.109.197442</pub-id>
<pub-id pub-id-type="pmid">19893003</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keepers</surname>
<given-names>TR</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>LK</given-names>
</name>
<name>
<surname>Obrig</surname>
<given-names>TG</given-names>
</name>
</person-group>
<article-title>Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome</article-title>
<source/>Infect Immun
          <year>2007</year>
<volume>75</volume>
<fpage>1229</fpage>
<lpage>1236</lpage>
<pub-id pub-id-type="doi">10.1128/IAI.01663-06</pub-id>
<pub-id pub-id-type="pmid">17220320</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liou</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>HB</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>YS</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model</article-title>
<source/>Pain
          <year>2012</year>
<volume>153</volume>
<fpage>1283</fpage>
<lpage>1291</lpage>
<pub-id pub-id-type="doi">10.1016/j.pain.2012.03.008</pub-id>
<pub-id pub-id-type="pmid">22494919</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liou</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Liao</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Day</surname>
<given-names>YJ</given-names>
</name>
</person-group>
<article-title>C-C chemokine ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury</article-title>
<source/>Sci Rep
          <year>2017</year>
<volume>7</volume>
<fpage>3698</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-03956-7</pub-id>
<pub-id pub-id-type="pmid">28623253</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gensel</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Is neuroinflammation in the injured spinal cord different than in the brain? Examining intrinsic differences between the brain and spinal cord</article-title>
<source/>Exp Neurol
          <year>2014</year>
<volume>258</volume>
<fpage>112</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/j.expneurol.2014.04.007</pub-id>
<pub-id pub-id-type="pmid">25017892</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Si</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MO</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Landau</surname>
<given-names>NR</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Vpr- and Nef-dependent induction of RANTES/CCL5 in microglial cells</article-title>
<source/>Virology
          <year>2002</year>
<volume>301</volume>
<fpage>342</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1006/viro.2002.1613</pub-id>
<pub-id pub-id-type="pmid">12359436</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>